Healthcare & Life Sciences Industry Updates

Google News – Oncology External News

Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push - Fierce Biotech

news.google.com · 20 Aug 2026

Google News – Oncology External News

Moderna Shares More Than Double on Success of mRNA Cancer Vaccine - WSJ

news.google.com · 20 Aug 2026

Google News – Oncology External News

mRNA cancer vaccine trial win ripples across biotech and oncology stocks - Investing.com

news.google.com · 20 Aug 2026

Google News – Oncology External News

Ryvu launches Keelira to support biotech and pharma companies with European Phase I/II development - Manufacturing Chemist

news.google.com · 20 Aug 2026

Google News – Oncology External News

AstraZeneca’s volrustomig hits Phase 3 setback in lung cancer - pharmaphorum

news.google.com · 20 Aug 2026

Google News – Oncology External News

Moderna cancer vaccine trial hits primary goal, stock surges 150% intraday; US pharma sector rallies - finance.biggo.com

news.google.com · 20 Aug 2026

Google News – Oncology External News

Xspray Pharma invites to a conference call following receipt of CRL for Dasynoc - TradingView

news.google.com · 20 Aug 2026

Google News – Oncology External News

AstraZeneca ends phase 3 lung cancer trial after bispecific falls short versus Keytruda - Fierce Biotech

news.google.com · 20 Aug 2026

Google News – Oncology External News

Biovica receives new extensive Pharma Services work order from existing customer - TradingView

news.google.com · 20 Aug 2026

Google News – Oncology External News

NATCO Pharma Targets Double-Digit Domestic Growth; Schedules Investor Meetings On August 24 and 26 - sahi.com

news.google.com · 20 Aug 2026

Google News – Oncology External News

GSK secures first lung cancer approval as FDA clears Jideytro in quick payoff from Nuvalent deal - Fierce Pharma

news.google.com · 20 Aug 2026

Google News – Oncology External News

Genmab (GMAB) Advances 1.91% to $31.94 as Oncology Biotech Names Rebound - OBV Divergence - Vinanet

news.google.com · 20 Aug 2026

Google News – Oncology External News

Agenus scraps phase 3 colorectal study after 3 months to narrow focus to colon cancer - Fierce Biotech

news.google.com · 20 Aug 2026

Google News – Oncology External News

Oncology Biotech Weekly: Eli Lilly's $7B In Vivo CAR-T Deal and the Unstoppable Rise of Precision Oncology - Oncodaily

news.google.com · 20 Aug 2026

Google News – Oncology External News

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching - 24/7 Wall St.

news.google.com · 20 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Technology transforms health human resources management - hospitalnews.com

SPARSH Hospitals Appoints Kalappa K.B. as Group Chief Human Resources Officer - hrtoday.in

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push - Fierce Biotech

Moderna Shares More Than Double on Success of mRNA Cancer Vaccine - WSJ

mRNA cancer vaccine trial win ripples across biotech and oncology stocks - Investing.com

Ryvu launches Keelira to support biotech and pharma companies with European Phase I/II development - Manufacturing Chemist

AstraZeneca’s volrustomig hits Phase 3 setback in lung cancer - pharmaphorum

Moderna cancer vaccine trial hits primary goal, stock surges 150% intraday; US pharma sector rallies - finance.biggo.com

Xspray Pharma invites to a conference call following receipt of CRL for Dasynoc - TradingView

AstraZeneca ends phase 3 lung cancer trial after bispecific falls short versus Keytruda - Fierce Biotech

Biovica receives new extensive Pharma Services work order from existing customer - TradingView

NATCO Pharma Targets Double-Digit Domestic Growth; Schedules Investor Meetings On August 24 and 26 - sahi.com

GSK secures first lung cancer approval as FDA clears Jideytro in quick payoff from Nuvalent deal - Fierce Pharma

Genmab (GMAB) Advances 1.91% to $31.94 as Oncology Biotech Names Rebound - OBV Divergence - Vinanet

Agenus scraps phase 3 colorectal study after 3 months to narrow focus to colon cancer - Fierce Biotech

Oncology Biotech Weekly: Eli Lilly's $7B In Vivo CAR-T Deal and the Unstoppable Rise of Precision Oncology - Oncodaily

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching - 24/7 Wall St.